[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100499949":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":48,"centralContacts":52,"locations":57,"responsibleParty":92,"collaborators":95,"id":97,"slug":98,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":31,"eligibilityCriteria":103,"healthyVolunteers":104,"sex":105,"minAge":106,"maxAge":31,"enrollmentInfo":107,"targetDuration":31,"studyType":110,"phases":111,"briefSummary":113,"conditions":114,"keywords":118,"overallStatus":60,"whyStopped":31,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":145},{"fullName":5,"class":6},"McGill University Health Centre\u002FResearch Institute of the McGill University Health Centre","OTHER",[8,13,18,22],{"label":9,"type":6,"description":10,"interventionNames":11},"MARVIN: a Chatbot for HIV patients","Co-construction of the chatbot, Usability study, Implementation, Evaluation of outcomes and Continuous improvements",[12],"Other: MARVIN",{"label":14,"type":6,"description":15,"interventionNames":16},"MARVIN: a Chatbot for Community Pharmacists","Co-construction of the chatbots, Usability study, Implementation, Evaluation of outcomes and Continuous improvements",[17],"Other: MARVIN-Pharma",{"label":19,"type":6,"description":15,"interventionNames":20},"MARVINA: a Chatbot for Breast Cancer Patients",[21],"Other: MARVINA",{"label":23,"type":6,"description":15,"interventionNames":24},"MARVIN CHAMP: a Chatbot for Pediatric Infectious Conditions",[25],"Other: MARVIN-CHAMP",[27,32,36,40],{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"MARVIN","Chatbot on Meta (Facebook) Messenger for HIV Patients",[9],null,{"type":6,"name":33,"description":34,"armGroupLabels":35,"otherNames":31},"MARVIN-Pharma","Chatbot on Meta (Facebook) Messenger for community pharmacists",[14],{"type":6,"name":37,"description":38,"armGroupLabels":39,"otherNames":31},"MARVINA","Chatbot on Meta (Facebook) Messenger for breast cancer patients",[19],{"type":6,"name":41,"description":42,"armGroupLabels":43,"otherNames":44},"MARVIN-CHAMP","CHatbot to Assist the Management of Pediatric patients with infectious conditions (CHAMP)",[23],[45,46,47],"CHatbot to Assist the Management of Pediatric patients with infectious conditions","CHAMP","CHAMPIONS",[49],{"name":50,"affiliation":5,"role":51},"Bertrand Lebouché, MD","PRINCIPAL_INVESTIGATOR",[53],{"name":50,"role":54,"phone":55,"phoneExt":31,"email":56},"CONTACT","514-843-2090","bertrand.lebouche@mcgill.ca",[58,78],{"facility":59,"status":60,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"Centre hospitalier de l'Université de Montréal (CHUM)","RECRUITING","Montreal","Quebec","H2X 3E4","Canada","CA",{"type":67,"coordinates":68},"Point",[69,70],-73.58781,45.50884,{"lat":70,"lon":69},[73],{"name":74,"role":54,"phone":75,"phoneExt":76,"email":77},"Marie-Pacale Pomey, MD, PhD","514 890 8000","14302","marie-pascale.pomey@umontreal.ca",{"facility":79,"status":60,"city":61,"state":62,"zip":80,"country":64,"countryCode":65,"cosmosGeoPoint":81,"geoPoint":83,"contacts":84},"McGill University Health Centre (MUHC)","H4A 3J1",{"type":67,"coordinates":82},[69,70],{"lat":70,"lon":69},[85,89],{"name":86,"role":54,"phone":87,"phoneExt":31,"email":88},"Bertrand Lebouché, MD, PhD","5148432090","bertrand.lecbouche@mcgill.ca",{"name":90,"role":91,"phone":31,"phoneExt":31,"email":31},"Esli Osmanlliu, MDCM, MSc","SUB_INVESTIGATOR",{"type":51,"investigatorFullName":93,"investigatorTitle":94,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Dr. Bertrand Lebouche","Clinical Scientist",[96],{"name":59,"class":6},"100499949","the-marvin-chatbots-to-provide-information-for-different-health-conditions-100499949",false,"NCT05789901","The MARVIN Chatbots to Provide Information for Different Health Conditions","A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots","Inclusion Criteria for all objectives:\n\n* being 14 years or older;\n* being fluent in English and\u002For French;\n* being able to understand the requirements of study participation and provide informed consent during the duration of the study;\n* having access to a smartphone, tablet, or computer at home\u002Fat workplace;\n* having access to an internet connection at home or data plan on their device.\n\nInclusion Criteria Specific to objectives 2 and 3:\n\n* accept to use a Facebook Messenger-based Chatbot;\n* accept to use or create a personal Facebook account;\n* accept Facebook's privacy and data security policies.\n\nExclusion Criteria:\n\n* not meeting the inclusion criteria\n* any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)",true,"ALL","14 Years",{"count":108,"type":109},400,"ESTIMATED","INTERVENTIONAL",[112],"NA","This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.",[115,116,117],"HIV Infections","Breast Cancer","Pediatric Emergency Medicine",[119,120,121,122,123,124,125,126,116,127,128,129,130,131,132,117,133,134,135],"Chatbot","Intelligent Conversational Agent","Co-Construction","Adherence","Antiretroviral Therapy","mHealth","Implementation Science","Care","HIV","Self-Management","Adaptive Platform Trial Design","Telehealth","Digital Health","Artificial Intelligence","Patient and Stakeholder Engagement","Pediatric Infection","Large Language Models","2024-03-04",{"date":138,"type":139},"2024-03-06","ACTUAL",{"date":141,"type":139},"2024-03-01",{"date":143,"type":109},"2034-12-31",{"name":5,"class":6},2]